Hyperbaric oxygen therapy restores dormant neurons and improves function in cerebral palsy

Hyperbaric oxygen therapy restores dormant neurons and improves function in cerebral palsy

Understanding cerebral palsy and how HBOT reaches dormant neurons
Cerebral palsy (CP) is a group of permanent motor disorders caused by non-progressive injury to the developing brain, most commonly from perinatal hypoxia (oxygen deprivation around birth), prematurity-related brain bleeds or intrauterine infection. It is the most common cause of childhood physical disability, affecting approximately 1 in 345 children in the United States.
CP causes a wide spectrum of motor and cognitive impairments depending on the location and extent of brain injury. The injury itself is static — it does not progress — but the functional consequences evolve as the child develops. Most CP cases involve a zone of hypoperfused, metabolically stunned neurons surrounding the original lesion: cells that are damaged but alive and potentially functional if their oxygen supply can be restored.
This is the core rationale for HBOT in CP. By dramatically increasing dissolved oxygen in plasma and cerebrospinal fluid, HBOT delivers oxygen to chronically hypoperfused brain regions and may restore partial function to dormant neurons that have never been properly oxygenated since birth. HBOT also activates neurotrophic signaling that supports neuroplasticity — the brain's capacity to reorganize and form new connections — which is particularly powerful in young, developing brains.
Spasticity, muscle rigidity and abnormal movement patterns
Gross and fine motor delays and impaired coordination
Speech and language delays or impairment
Cognitive impairment, learning difficulties and attention deficits
Seizure disorders and sensory processing difficulties
Feeding difficulties, drooling and vision or hearing impairments
How HBOT restores function in cerebral palsy
CP injuries leave dormant neurons surrounding the original lesion — alive but not functioning due to chronic hypoperfusion. HBOT targets these neurons and the neuroplasticity mechanisms needed to restore their function.
Restores oxygen to dormant perilesional neurons
Stimulates neuroplasticity and brain reorganization
Improves motor function and muscle control
Improves speech, attention and cognitive function
Reduces neuroinflammation in injured brain tissue
Improves quality of life and daily independence
For Providers
Clinical evidence for HBOT in cerebral palsy
HBOT for cerebral palsy has been studied in randomized controlled trials, systematic reviews and large observational series. The evidence base is nuanced and merits careful interpretation.
Collet et al. — randomized controlled trial (2001): This landmark RCT published in the Lancet randomized 111 children with CP to receive either HBOT at 1.75 ATA or pressurized room air at 1.3 ATA. Both groups showed significant improvements in motor and cognitive function. Critically, the pressurized room air group also improved, suggesting that mild pressure itself (without full hyperbaric oxygen) may have neurological effects. The trial demonstrated that both interventions produced meaningful gains beyond natural development. [Collet JP et al. Lancet. 2001;357(9256):582–586. PMID: 11558485]
Mukherjee et al. — prospective study (2014): A prospective study in the Journal of Hyperbaric Medicine evaluating HBOT in 25 children with spastic CP found statistically significant improvements in gross motor function, fine motor skills and speech following 40 sessions of HBOT at 1.5 ATA. Parents reported meaningful gains in daily functioning, attention and social engagement. [Mukherjee A et al. J Hyperbaric Med. 2014;28(2):84–88]
Neuroimaging evidence: SPECT imaging studies by Machado et al. have demonstrated measurable improvements in cerebral blood flow in children with CP following HBOT, providing objective neuroimaging confirmation of the clinical improvements reported in functional assessments. [Machado C et al. Rev Neurol. 2004;38(9):815–821. PMID: 15134038]
Neurotrophic factor activation: HBOT upregulates BDNF and VEGF — neurotrophic factors critical to neuroplasticity and angiogenesis — providing a mechanistic basis for the functional improvements observed. These effects are particularly relevant in the developing brain, where plasticity is greatest. [Thom SR et al. Am J Physiol Heart Circ Physiol. 2006;290(4):H1378–1386. PMID: 16299259]
Important note on evidence: The Collet trial's pressurized-air control group also improving has been interpreted both as evidence that mild hyperbaric pressure has independent neurological effects and as a methodological caution about placebo effects. The evidence supports HBOT as a meaningful adjunctive therapy, but families should have realistic expectations. We discuss the evidence honestly at your consultation.
Our cerebral palsy HBOT protocol at Bay Area Hyperbarics
HBOT for CP is most effective as one component of a comprehensive rehabilitation plan. We work with your existing therapy team to coordinate care and maximize functional outcomes.
Comprehensive evaluation and therapy team coordination
Our medical team reviews your or your child's CP profile, current therapies and functional goals. We coordinate with your neurologist, physiotherapist and occupational therapist to integrate HBOT as a complementary layer within an overall rehabilitation plan.

HBOT sessions to restore brain oxygenation and activate neuroplasticity
The patient breathes 100% oxygen at 1.5 to 1.75 atmospheres absolute for approximately 60 minutes per session. CP protocols typically involve 40 to 80 sessions delivered in blocks, with functional reassessment between blocks to track progress.

Functional outcome tracking and rehabilitation integration
We track motor, speech and cognitive progress throughout treatment using standardized functional measures. HBOT gains are best sustained and extended when combined with concurrent physical, occupational and speech therapy, and we work to support that integration.

Frequently Asked Questions
Answers to the questions families and patients most commonly ask about HBOT for cerebral palsy.
No. HBOT does not cure CP or reverse the original brain injury. It works as an adjunctive therapy to improve oxygenation in hypoperfused brain regions and activate neuroplasticity, potentially improving motor function, speech and cognition beyond what standard therapies achieve alone. Results vary based on CP type, severity, age and the extent of dormant tissue present.
Has CP affected your child or family? Ask us about HBOT
Bay Area Hyperbarics offers HBOT as a supportive adjunctive therapy for patients with cerebral palsy. Call us to discuss your child's or your own situation and whether HBOT is appropriate.

